Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.The University of California Los Angeles (UCLA) and eResearchTechnology (ERT) have initiated the CLEAR Study for patients suffering from chronic obstructive pulmonary disease (COPD).
Subscribe to our email newsletter
The randomized study is designed to test whether remote health monitoring is feasible in patients with moderate-severe COPD, improves treatment adherence, symptoms, activity level and quality of life.
The twelve month will enable early detection of COPD exacerbations, facilitating early interventions and reducing health related expenditures.
The enrollees will track their lung function using ERT’s SpiroPro which will also record symptoms through questions of the CLEAR Sx Assessment instrument.
The devices will also deliver the new CLEAR Rx and CLEAR Ex Assessment instruments to determine prescription adherence and perceived activity levels.
A wearable accelerometer is used by the enrollees to record their physical activity levels. All the data will be uploaded to a web based data tracking site.
The first patient of over 200 patients is expected to be recruited starting in February, 2012 and patient outcomes will be reported in late 2013, the company said.
ERT chief development officer John Sory said the combined efforts of UCLA and ERT will test new approaches and could well deliver a meaningful new approach for the benefit of patients.